Natera CLO Executes $1.65M Sale via 10b5-1 Plan
Natera, Inc.
Subscribe to track NTRA
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Natera CLO Executes $1.65M Sale via 10b5-1 Plan
Company: Natera, Inc. (NTRA) Form: 4 | Filed: 2026-03-10 Significance: Low
Insider: RABINOWITZ DANIEL Title: SEC. AND CHIEF LEGAL OFFICER
Transaction: • Type: Sale (following Option Exercise) • Shares: 8,398 sold (5,598 exercised) • Avg Price: ~$196.08 • Total Value: ~$1.65 Million • Owned After: 233,285
Key Insight: Routine transaction pursuant to a 10b5-1 plan adopted in Dec 2025. The sale represents <0.01% of the company's $28B market cap.
Market Context: Natera is a large-cap ($28.08B) company; this transaction volume is negligible relative to daily liquidity.
Comprehensive Analysis
SEC Filing Analysis: Natera, Inc. (NTRA)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Chief Legal Officer exercises options and sells shares under a pre-arranged 10b5-1 trading plan.
- Market Impact: Neutral - Transaction size is immaterial relative to market capitalization.
Company Information
| Field | Value |
|---|---|
| Company | Natera, Inc. |
| Ticker Symbol | NTRA |
| CIK | 0001604821 |
| Industry | Services - Medical Laboratories |
Insider Information
| Field | Value |
|---|---|
| Name | RABINOWITZ DANIEL |
| CIK | 0001857843 |
| Title/Position | SEC. AND CHIEF LEGAL OFFICER |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2026-03-06 |
| Transaction Code | M (Exercise) & S (Sale) |
| Security Type | Common Stock |
| Shares Sold | 8,398 |
| Shares Exercised | 5,598 |
| Avg Price Per Share | ~$196.08 |
| Total Sale Value | ~$1,646,696 |
| Shares Owned After | 233,285 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $1.65 Million |
| % of Market Cap | 0.0059% |
| Shares Transacted | 8,398 |
| % of Shares Outstanding | 0.0059% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: With a market cap of $28.08 billion, a $1.65 million transaction is statistically insignificant.
- Ownership Concentration: The insider retains 233,285 shares (valued at ~$45.7M), indicating the sale represents only ~3.5% of their direct holdings.
- Dilution Impact: The exercise of 5,598 options creates negligible dilution (<0.004% of outstanding shares).
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The sale was conducted under a Rule 10b5-1 plan adopted on December 5, 2025, removing discretionary timing. The volume is too low to impact price discovery.
Volume & Sentiment
- Expected Volume Impact: None.
- Sentiment Indicator: Neutral. This appears to be standard executive compensation realization rather than a lack of confidence in the company.
Additional Context
Transaction Notes
- 10b5-1 Plan: Yes, adopted 2025-12-05.
- Structure: The insider exercised 5,598 options at $19.68 and sold a total of 8,398 shares at prices ranging from ~$193 to ~$198. This resulted in a net reduction of share count by 2,800 shares.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.